Reducing race differences in direct-to-consumer pharmaceutical advertising : the case for regulation /

This book examines whether direct-to-consumer pharmaceutical advertising changed in response to recommendations made by the FDA in 2009 to enhance the informational and motivational value of advertising to be more accessible to minority populations and consequently work to reduce health disparities.

Détails bibliographiques
Cote:Libro Electrónico
Auteurs principaux: De Scisciolo, Stephany, 1958- (Auteur), Scheid, Teresa L. (Auteur)
Format: Électronique eBook
Langue:Inglés
Publié: Lanham, Maryland : Lexington Books, an imprint of The Rowman & Littlefield Publishing Group, Inc., [2018]
Sujets:
Advertising > Drugs > United States.
Direct-to-consumer prescription drug advertising > United States.
Discrimination in the advertising industry > United States.
Discrimination in medical care > United States.
Médicaments > Publicité > États-Unis.
Publicité directe des médicaments d'ordonnance > États-Unis.
Discrimination dans les soins médicaux > États-Unis.
BUSINESS & ECONOMICS > Advertising & Promotion.
Advertising > Drugs
Direct-to-consumer prescription drug advertising
Discrimination in medical care
Discrimination in the advertising industry
United States
Accès en ligne:Texto completo

Internet

Texto completo

Items no disponibles

Informations d'exemplaires de

Documents similaires